Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Assets
- Common-Size Income Statement
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Price to FCFE (P/FCFE)
- Present Value of Free Cash Flow to Equity (FCFE)
- Operating Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Regeneron Pharmaceuticals Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in thousands
Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Accounts payable
- Accounts payable exhibits a fluctuating pattern over the reported periods, with values generally ranging from approximately 347,800 to 789,500 thousand US dollars. Noticeable peaks occur towards the end of 2024 and early 2025, indicating cycles of increased supplier obligations.
- Accrued expenses and other current liabilities
- This category shows a general upward trend with occasional decreases, starting around 1,228,200 thousand and peaking beyond 2,644,700 thousand by late 2023. The fluctuations suggest varying accruals tied to operational expenses or other short-term commitments.
- Debt
- Debt values are sparse, with a reported amount only in June 2020 at 1,500,000 thousand. Finance lease liabilities have consistent values in the 700,000+ thousand range with both current and non-current portions reported separately, indicating ongoing lease obligations.
- Deferred revenue
- Two separate entries for deferred revenue show differing trends. The first deferred revenue series ranges between 27,000 and 627,700 thousand, showing variability but a slight upward movement toward early 2025. The second series fluctuates between 27,000 and approximately 126,700 thousand, increasing steadily from 2023, which may reflect evolving contractual revenues.
- Current liabilities
- Current liabilities present significant volatility, moving between approximately 2,057,200 thousand and over 3,940,000 thousand. After peaking mid-2021, there is a noticeable reduction followed by a rising trend again in 2024, possibly reflecting changes in short-term financial obligations.
- Long-term debt
- Long-term debt remained stable and steadily increased slightly from 1,978,300 thousand to approximately 1,985,100 thousand over several quarters, suggesting limited new long-term borrowings but ongoing slight increases year-over-year.
- Other noncurrent liabilities
- Other noncurrent liabilities trend upward from 772,000 thousand to over 1,700,000 thousand, showing a consistent increase especially from 2023 onwards, which could be associated with deferred obligations or long-term accrued expenses.
- Noncurrent liabilities
- Noncurrent liabilities demonstrate substantial increases, particularly between 2020 and 2025, moving from around 1,569,300 thousand to over 4,613,300 thousand, indicating growing long-term obligations.
- Total liabilities
- Total liabilities have risen considerably from about 3,624,500 thousand to over 8,280,300 thousand, reflecting intensifying obligations in both current and noncurrent categories, supporting the inference of expansion or increased financing activities.
- Stockholders' equity components
- Common stock remains constant throughout the periods at 100 thousand, indicating no new issuances or repurchases affecting par value. Additional paid-in capital shows consistent growth from around 5,211,400 thousand to nearly 13,490,800 thousand, reflecting equity raises or retained earnings capitalizations.
- Retained earnings steadily increase from approximately 8,004,400 thousand to about 33,680,200 thousand, indicating persistent profitability or retained profit retention. Accumulated other comprehensive income fluctuates between losses and gains, with no strong directional trend, suggesting variable impacts from other comprehensive elements such as currency translation or unrealized gains/losses.
- Treasury stock consistently increases in absolute value (negative amounts) from -1,073,800 thousand to -17,284,700 thousand, pointing to ongoing share repurchase activity, which reduces outstanding shares and impacts equity.
- Stockholders’ equity
- Stockholders’ equity grows from about 12,133,000 thousand to nearly 30,000,000 thousand, illustrating overall strengthening of equity base, mostly driven by increasing retained earnings and additional paid-in capital despite the treasury stock reductions.
- Total liabilities and stockholders’ equity
- The combined total grows from roughly 15,757,500 thousand to over 38,219,200 thousand, highlighting significant expansion of the company’s financial position through increased liabilities and equity.